Search results for: South Korea
Filter search results
Can Transparency Lower Prices and Improve Access to Pharmaceuticals? Five Questions We Think Matter a Lot
29 March 2019
…The UK figures are similar. In contrast, in some of the poorest SSA and South Asian markets, the volume/value relationship between generics’ volume and spend is roughly 1:1. So, when…
New Publication: Bibliometric Trends of Health Economic Evaluation in Sub-Saharan Africa
8 November 2016
…between countries. A rapid evidence assessment was conducted that includes economic evaluations carried out in 20 sub-Saharan countries: Angola, Botswana, Congo, Lesotho, Madagascar, Malawi, Mauritius, Mozambique, Namibia, Seychelles, South Africa,…
Raoh-Fang Pwu
15 May 2023
…served on the INAHTA Board from 2010 to 2012 and, together with her HTA colleagues from Thailand and Korea, founded HTAsiaLink in 2010, where she assumed the role of President…
HTA and Decision Making in Asia: How can the available resources be used most effectively to deliver high quality HTA that can be used by health system decision makers?
4 January 2017
…of the use of HTA in each of the health systems represented at the meeting: China, Japan, Korea, Malaysia, Philippines, Singapore, Taiwan and Thailand. The background papers from the 2014,…
HTAi Asia Policy Forum Briefing Papers: Value and Affordability, Transferability, and Delivery of High Quality HTA for Decision Making
2 May 2017
…short appendices which provide an overview of the use of HTA in each of the health systems represented at the meeting: China, Japan, Korea, Malaysia, Philippines, Singapore, Taiwan and Thailand….
OHE at HTAi Oslo: A New Drug Development Paradigm, and the Effect of NICE Decisions Abroad
19 June 2015
…of 29 drug/indication pairs and a group of 15 countries were studied (Australia, Canada, Denmark, France, Italy, Korea, Netherlands, New Zealand, Poland, Portugal, Spain, Bosnia, Ecuador, Egypt and Ghana). The…
OHE at HTAi Oslo: A New Drug Development Paradigm, a Framework for Developing Formularies in MICs, and the Effect of NICE Decisions Abroad
15 June 2015
…Denmark, France, Italy, Korea, Netherlands, New Zealand, Poland, Portugal, Spain, Bosnia, Ecuador, Egypt and Ghana). Information regarding NICE HTA recommendations was extracted from NICE’s website and HTAinSite.com, and additional information…
OHE at ISPOR Europe 1: Impact of NICE on Innovation and Value
22 October 2014
…publicly available sources and an online survey. The countries included are Australia, Canada, Denmark, France, Italy, Korea, The Netherlands, New Zealand, Poland, Portugal, Spain, Bosnia-Herzegovina, Ecuador, Egypt and Ghana. (PHP86,…
Press Release: Proposed International Price Index Effectively Outsources Pharmaceutical Policy Decisions to Other Countries
29 October 2019
…was funded by PhRMA through OHE Consulting Ltd, a subsidiary of the Office of Health Economics. Contact Details Office of Health Economics 7th Floor Southside 105 Victoria Street London, UK…